{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:34:04Z","timestamp":1790512444999,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,4,25]],"date-time":"2008-04-25T00:00:00Z","timestamp":1209081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s10549-008-0019-0","type":"journal-article","created":{"date-parts":[[2008,4,24]],"date-time":"2008-04-24T21:59:36Z","timestamp":1209074376000},"page":"517-525","source":"Crossref","is-referenced-by-count":76,"title":["High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome"],"prefix":"10.1007","volume":"114","author":[{"given":"Pamela J.","family":"Goodwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. George","family":"Fantus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen I.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen E.","family":"Trudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarley","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,25]]},"reference":[{"key":"19_CR1","doi-asserted-by":"crossref","unstructured":"Seidell JC (2005) Epidemiology of obesity. Semin Vasc Med 5:3\u201314","DOI":"10.1055\/s-2005-871737"},{"key":"19_CR2","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1200\/JCO.2002.20.4.1128","volume":"20","author":"RT Chlebowski","year":"2002","unstructured":"Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20:1128\u20131143","journal-title":"J Clin Oncol"},{"key":"19_CR3","first-page":"405","volume-title":"Cancer prevention and management through exercise and weight control","author":"PJ Goodwin","year":"2006","unstructured":"Goodwin PJ (2006) Energy balance and cancer prognosis: breast cancer. In: McTiernan A (ed) Cancer prevention and management through exercise and weight control. CRC Press, Boca Raton, FL, pp 405\u2013435"},{"key":"19_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1200\/JCO.2002.20.1.42","volume":"20","author":"PJ Goodwin","year":"2002","unstructured":"Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42\u201351","journal-title":"J Clin Oncol"},{"key":"19_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ijc.21812","volume":"119","author":"P Pasanisi","year":"2006","unstructured":"Pasanisi P, Berrino F, De Petris M et al (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236\u2013238","journal-title":"Int J Cancer"},{"key":"19_CR6","doi-asserted-by":"crossref","unstructured":"Pollak MN, Chapman JW, Shepherd L et al (2006) Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial. In: Grunberg SM (ed) Proceedings of the 42nd American society of clinical oncology annual meeting, Georgia, June 2006. Supplement to Journal of Clinical Oncology, vol 24. American Society of Clinical Oncology, Alexandria, VA, p 9s","DOI":"10.1200\/jco.2006.24.18_suppl.524"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nutr.24.012003.132155","volume":"25","author":"GM Reaven","year":"2005","unstructured":"Reaven GM (2005) The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 25:391\u2013406","journal-title":"Annu Rev Nutr"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K et al (2003) Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625\u20131638","journal-title":"N Engl J Med"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579\u2013591","journal-title":"Nat Rev Cancer"},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1023\/A:1020239211145","volume":"13","author":"LM Morimoto","year":"2002","unstructured":"Morimoto LM, White E, Chen Z et al (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women\u2019s Health Initiative (United States). Cancer Causes Control 13:741\u2013751","journal-title":"Cancer Causes Control"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jama.1997.03550170037029","volume":"278","author":"Z Huang","year":"1997","unstructured":"Huang Z, Hankinson SE, Colditz GA et al (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407\u20131411","journal-title":"JAMA"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/B:CACO.0000024225.14618.a8","volume":"15","author":"DA Lawlor","year":"2004","unstructured":"Lawlor DA, Smith GD, Ebrahim S (2004) Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women\u2019s Heart and Health Study. Cancer Causes Control 15:267\u2013275","journal-title":"Cancer Causes Control"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3835(96)04211-5","volume":"104","author":"D Yam","year":"1996","unstructured":"Yam D, Fink A, Mashiah A et al (1996) Hyperinsulinemia in colon, stomach and breast cancer patients. Cancer Lett 104:129\u2013132","journal-title":"Cancer Lett"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1005831013718","volume":"47","author":"ME Del Giudice","year":"1998","unstructured":"Del Giudice ME, Fantus IG, Ezzat S et al (1998) Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47:111\u2013120","journal-title":"Breast Cancer Res Treat"},{"key":"19_CR15","first-page":"1207","volume":"10","author":"G Yang","year":"2001","unstructured":"Yang G, Lu G, Jin F et al (2001) Population-based, case\u2013control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10:1207\u20131211","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/cncr.20023","volume":"100","author":"A Malin","year":"2004","unstructured":"Malin A, Dai Q, Yu H et al (2004) Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Cancer 100:694\u2013700","journal-title":"Cancer"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.2910520402","volume":"52","author":"PF Bruning","year":"1992","unstructured":"Bruning PF, Bonfrer JM, van Noord PA et al (1992) Insulin resistance and breast-cancer risk. Int J Cancer 52:511\u2013516","journal-title":"Int J Cancer"},{"key":"19_CR18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/diacare.21.2.310","volume":"21","author":"American Diabetes Association","year":"1998","unstructured":"American Diabetes Association (1998) Consensus Development Conference on Insulin Resistance. Diabetes Care 21:310\u2013314","journal-title":"Diabetes Care"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1464-5491.2002.00745.x","volume":"19","author":"TM Wallace","year":"2002","unstructured":"Wallace TM, Matthews DR (2002) The assessment of insulin resistance in man. Diabet Med 19:527\u2013534","journal-title":"Diabet Med"},{"key":"19_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57\u201363","journal-title":"Diabetes Care"},{"key":"19_CR21","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K et al (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402\u20132410","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diacare.24.3.460","volume":"24","author":"KA McAuley","year":"2001","unstructured":"McAuley KA, Williams SM, Mann JI et al (2001) Diagnosing insulin resistance in the general population. Diabetes Care 24:460\u2013464","journal-title":"Diabetes Care"},{"key":"19_CR23","doi-asserted-by":"crossref","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486\u20132497","DOI":"10.1001\/jama.285.19.2486"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539\u2013553","journal-title":"Diabet Med"},{"key":"19_CR25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/oxfordjournals.aje.a114416","volume":"124","author":"G Block","year":"1986","unstructured":"Block G, Hartman AM, Dresser CM et al (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124:453\u2013469","journal-title":"Am J Epidemiol"},{"key":"19_CR26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/oxfordjournals.aje.a113987","volume":"121","author":"JF Sallis","year":"1985","unstructured":"Sallis JF, Haskell WL, Wood PD et al (1985) Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 121:91\u2013106","journal-title":"Am J Epidemiol"},{"key":"19_CR27","unstructured":"National Institutes of Health (1982) Manual of laboratory operations, lipid research clinics program: I. Lipid and lipoprotein analysis. Bethesda, MD"},{"key":"19_CR28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11892-003-0057-2","volume":"3","author":"JB Meigs","year":"2003","unstructured":"Meigs JB (2003) Epidemiology of the insulin resistance syndrome. Curr Diab Rep 3:73\u201379","journal-title":"Curr Diab Rep"},{"key":"19_CR29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","volume":"163","author":"YW Park","year":"2003","unstructured":"Park YW, Zhu S, Palaniappan L et al (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988\u20131994. Arch Intern Med 163:427\u2013436","journal-title":"Arch Intern Med"},{"key":"19_CR30","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1464-5491.2004.01294.x","volume":"21","author":"ME Jorgensen","year":"2004","unstructured":"Jorgensen ME, Bjerregaard P, Gyntelberg F et al (2004) Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diabet Med 21:1237\u20131242","journal-title":"Diabet Med"},{"key":"19_CR31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2337\/diacare.26.3.575","volume":"26","author":"ES Ford","year":"2003","unstructured":"Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26:575\u2013581","journal-title":"Diabetes Care"},{"key":"19_CR32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1464-5491.2004.01115.x","volume":"21","author":"G Marchesini","year":"2004","unstructured":"Marchesini G, Forlani G, Cerrelli F et al (2004) WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med 21:383\u2013387","journal-title":"Diabet Med"},{"key":"19_CR33","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2337\/diacare.27.4.978","volume":"27","author":"Y Liao","year":"2004","unstructured":"Liao Y, Kwon S, Shaughnessy S et al (2004) Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 27:978\u2013983","journal-title":"Diabetes Care"},{"key":"19_CR34","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2337\/diabetes.53.5.1195","volume":"53","author":"KL Cheal","year":"2004","unstructured":"Cheal KL, Abbasi F, Lamendola C et al (2004) Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53:1195\u20131200","journal-title":"Diabetes"},{"key":"19_CR35","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","volume":"26","author":"JF Ascaso","year":"2003","unstructured":"Ascaso JF, Pardo S, Real JT et al (2003) Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 26:3320\u20133325","journal-title":"Diabetes Care"},{"key":"19_CR36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diabetes.47.5.699","volume":"47","author":"N Ruderman","year":"1998","unstructured":"Ruderman N, Chisholm D, Pi-Sunyer X et al (1998) The metabolically obese, normal-weight individual revisited. Diabetes 47:699\u2013713","journal-title":"Diabetes"},{"key":"19_CR37","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1152\/japplphysiol.00695.2005","volume":"99","author":"NM Punjabi","year":"2005","unstructured":"Punjabi NM, Polotsky VY (2005) Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99:1998\u20132007","journal-title":"J Appl Physiol"},{"key":"19_CR38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00125-004-1604-3","volume":"48","author":"C Meisinger","year":"2005","unstructured":"Meisinger C, Heier M, Loewel H (2005) Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 48:235\u2013241","journal-title":"Diabetologia"},{"key":"19_CR39","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1152\/japplphysiol.00660.2005","volume":"99","author":"K Spiegel","year":"2005","unstructured":"Spiegel K, Knutson K, Leproult R et al (2005) Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99:2008\u20132019","journal-title":"J Appl Physiol"},{"key":"19_CR40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/BD-2003-17108","volume":"17","author":"F Frasca","year":"2003","unstructured":"Frasca F, Pandini G, Vigneri R et al (2003) Insulin and hybrid insulin\/IGF receptors are major regulators of breast cancer cells. Breast Dis 17:73\u201389","journal-title":"Breast Dis"},{"key":"19_CR41","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/jnci\/94.13.972","volume":"94","author":"MS Sandhu","year":"2002","unstructured":"Sandhu MS, Dunger DB, Giovannucci EL (2002) Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 94:972\u2013980","journal-title":"J Natl Cancer Inst"},{"key":"19_CR42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF00051703","volume":"7","author":"R Kaaks","year":"1996","unstructured":"Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7:605\u2013625","journal-title":"Cancer Causes Control"},{"key":"19_CR43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jcem-67-3-460","volume":"67","author":"SR Plymate","year":"1988","unstructured":"Plymate SR, Matej LA, Jones RE et al (1988) Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 67:460\u2013464","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR44","first-page":"4429s","volume":"7","author":"AV Lee","year":"2001","unstructured":"Lee AV, Cui X, Oesterreich S (2001) Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer. Clin Cancer Res 7:4429s\u20134435s","journal-title":"Clin Cancer Res"},{"key":"19_CR45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1009575518338","volume":"5","author":"D Yee","year":"2000","unstructured":"Yee D, Lee AV (2000) Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 5:107\u2013115","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"19_CR46","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-142-8-200504190-00009","volume":"142","author":"TJ Orchard","year":"2005","unstructured":"Orchard TJ, Temprosa M, Goldberg R et al (2005) The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 142:611\u2013619","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"19_CR47","first-page":"A2085","volume":"100","author":"PJ Goodwin","year":"2006","unstructured":"Goodwin PJ, Pritchard KI, Fantus IG, Ennis M, Clemons M, Graham M (2006) Metformin lowers fasting insulin levels in hyperinsulinemia early stage breast cancer patients\u2013\u2013results of a phase II study. Breast Cancer Res Treat 100(Suppl 1):A2085","journal-title":"Breast Cancer Res Treat"},{"key":"19_CR48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1200\/JCO.2007.12.7357","volume":"26","author":"JA Ligibel","year":"2008","unstructured":"Ligibel JA, Campbell N, Partridge A et al (2008) Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 26:907\u2013912","journal-title":"J Clin Oncol"},{"key":"19_CR49","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1200\/JCO.2007.14.7132","volume":"26","author":"PJ Goodwin","year":"2008","unstructured":"Goodwin PJ (2008) Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic intervention? J Clin Oncol 26:833\u2013834","journal-title":"J Clin Oncol"},{"key":"19_CR50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/djn014","volume":"200","author":"J-A Chapman","year":"2008","unstructured":"Chapman J-A, Meng D, Shepherd L et al (2008) Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst 200:252\u2013260","journal-title":"J Natl Cancer Inst"},{"key":"19_CR51","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jnci\/djh253","volume":"96","author":"C Schairer","year":"2004","unstructured":"Schairer C, Mink PJ, Carroll L et al (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96:1311\u20131321","journal-title":"J Natl Cancer Inst"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0019-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-008-0019-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0019-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T19:22:56Z","timestamp":1588620176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-008-0019-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,25]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s10549-008-0019-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,25]]}}}